Benzinga's Top Upgrades
Analysts at Credit Suisse upgraded USG (NYSE: USG) from “underperform” to “neutral.” The target price for USG has been raised from $22 to $27. USG's stock closed at $24.55 on Friday.
Analysts at Compass Point upgraded First Horizon National (NYSE: FHN) from “sell” to “neutral.” The target price for First Horizon National has been raised from $9.50 to $10. First Horizon National's shares closed at $9.90 on Friday.
JP Morgan upgraded Perrigo Company (NASDAQ: PRGO) from “neutral” to “overweight.” The target price for Perrigo has been raised from $120 to $132. Perrigo's shares closed at $119.47 on Friday.
Morgan Stanley upgraded AbbVie (NYSE: ABBV) from “equal weight” to “overweight.” The target price for AbbVie has been raised from $36 to $49. AbbVie's shares closed at $42.39 on Friday.
Latest Ratings for USG
|Jan 2017||Barclays||Initiates Coverage On||Underweight|
|Nov 2016||Goldman Sachs||Reinstates||Sell|
|Nov 2016||Evercore ISI Group||Initiates Coverage On||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.